These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4123456)

  • 21. Cellular immunity in human osteogenic sarcoma.
    Gangal SG; Agashe SS; Nair PN; Rao RS
    Indian J Cancer; 1973 Sep; 10(3):295-301. PubMed ID: 4522531
    [No Abstract]   [Full Text] [Related]  

  • 22. Similarities of Fc receptors in human malignant tissue and normal lymphoid tissue.
    Tonder O; Morse PA; Humphrey LJ
    J Immunol; 1974 Oct; 113(4):1162-9. PubMed ID: 4472307
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor-specific cell-mediated immunity in household contacts of cancer patients.
    Byers VS; Levin AS; Hackett AJ; Fudenberg HH
    J Clin Invest; 1975 Mar; 55(3):500-13. PubMed ID: 1078827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line.
    Drewinko B; Montgomery CT; Trujillo JM
    Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of immunology in the diagnosis, prognosis and treatment planning of oral cancer.
    Shillitoe EJ
    Proc R Soc Med; 1976 Oct; 69(10):747-9. PubMed ID: 186794
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 28. Viral and immunologic studies of human neoplasms.
    Malmgren RA; Morton DL
    Pathobiol Annu; 1971; 1():63-81. PubMed ID: 4359566
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
    Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P
    Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuraminidase immunotherapy of tumors in man.
    Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
    Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell-mediated and humoral immune reactions to human tumours.
    Baldwin RW; Embleton MJ; Jones JS; Langman MJ
    Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
    [No Abstract]   [Full Text] [Related]  

  • 32. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic lymphocytes. II. Antagonism and synergism between serum factors and lymphocytes of patients with sarcomas as tested against cultured tumor cells.
    Sinkovics JG; Ahmed N; Hrgovcic MJ; Cabiness JR; Wilbur JR
    Tex Rep Biol Med; 1972; 30(4):347-60. PubMed ID: 4121149
    [No Abstract]   [Full Text] [Related]  

  • 34. The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
    Adair SJ; Carr TM; Fink MJ; Slingluff CL; Hogan KT
    J Immunother; 2008 Jan; 31(1):7-17. PubMed ID: 18157007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular immunity to human tumor-associated antigens. A review.
    Herberman RB
    Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cancer and immunity].
    Nagel GA; Geiger C
    Schweiz Med Wochenschr; 1971 Nov; 101(45):1605-20. PubMed ID: 4947152
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell- and antibody-mediated immune reactions of patients to cultured cells of breast carcinoma.
    Sinkovics JG; Reeves WJ; Cabiness JR
    J Natl Cancer Inst; 1972 Apr; 48(4):1145-9. PubMed ID: 5023675
    [No Abstract]   [Full Text] [Related]  

  • 38. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of cellular immunity indices in patients with malignant tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA
    Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of cell-mediated immunity to human tumor-associated antigens.
    Baldwin RW; Embeton MJ
    Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.